Silke Mohl

Title: Silke Mohl: Innovator in Lipid Particle Technology

Introduction

Silke Mohl is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of lipid particle technology, particularly through her innovative patent. Her work focuses on the development of lipid particles that incorporate apolipoproteins and phospholipids, which have important applications in biomedicine.

Latest Patents

Silke Mohl holds a patent titled "Tetranectin-apolipoprotein A-I, lipid particles containing it and its use." This patent describes a lipid particle that comprises an apolipoprotein, a phosphatidylcholine, and a lipid, such as a phospholipid, fatty acid, or steroid lipid. The invention includes various embodiments, such as lipid particles consisting of a single apolipoprotein and a phospholipid, as well as specific variations in fatty acid residues. This innovative approach has the potential to enhance the efficacy of lipid-based therapies.

Career Highlights

Silke Mohl is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. Her work at the company has allowed her to further develop her research and contribute to advancements in lipid particle technology.

Collaborations

Silke collaborates with esteemed colleagues, including Martin Bader and Monika Baehner. Their combined expertise fosters a productive research environment that drives innovation in their field.

Conclusion

Silke Mohl's contributions to lipid particle technology exemplify the impact of innovative research in biomedicine. Her patent and collaborative efforts highlight the importance of teamwork in advancing scientific knowledge and applications.